Timing of Estradiol Treatment After Menopause May Determine Benefit or Harm to Insulin Action
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Type 2 diabetes (T2D) is reduced in postmenopausal women randomized to estrogen-based hormone therapy (HT) compared with placebo. Insulin sensitivity is a key determinant of T2D risk and overall cardiometabolic health, and studies indicate that estradiol (E2) directly impacts insulin action. OBJECTIVE: We hypothesized that the timing of E2 administration after menopause is an important determinant of its effect on insulin action. DESIGN: We performed a randomized, crossover, placebo-controlled study. PARTICIPANTS: Study participants were early postmenopausal (EPM; ≤ 6 years of final menses; n = 22) and late postmenopausal (LPM; ≥ 10 years since last menses; n = 24) women naive to HT. INTERVENTION: Study interventions included short-term (1 week) transdermal E2 and placebo. MAIN OUTCOMES AND MEASURES: The study's main outcome was insulin-mediated glucose disposal (glucose disposal rate [GDR]) via hyperinsulinemic-euglycemic clamp. RESULTS: Compared to EPM women, LPM women were older (mean ± SD; 63 ± 3 vs 56 ± 4 years, P < .05) and more years past menopause (12 ± 2 vs 3 ± 2 years, P < .05). Body mass index (24 ± 3 vs 25 ± 7 kg/m(2)) and fat mass (25 ± 7 vs 23 ± 6 kg) did not differ between groups, but fat-free mass (FFM) was lower in LPM women compared to EPM women (40 ± 4 vs 43 ± 5 kg, P < .05). Baseline GDR did not differ between groups (11.7 ± 2.8 vs 11.5 ± 2.9 mg/kg FFM/min). In support of our hypothesis, 1 week of E2 decreased GDR in LPM women compared to an increase in EPM women (+0.44 ± 1.7 vs - 0.76 ± 2.1 mg/kg FFM/min, P < .05). CONCLUSIONS: There was not an apparent decline in GDR with age or time since menopause per se. However, E2 action on GDR was dependent on time since menopause, such that there was an apparent benefit early (≤ 6 years) compared to harm later (≥ 10 years) in menopause. E2-mediated effects on insulin action may be one mechanism by which HT reduces the incidence of T2D in early postmenopausal women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many studies have shown that E2 beneficially influences metabolism through mechanisms involving reduced food intake and increased energy expenditure (75, 129–131).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [131]
Citations
Cites
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
The role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
A survey for assessing physical activity among older adults
DIPIETRO, L., CASPERSEN, C. J., OSTFELD, A. M., & NADEL, E. R. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199305000-00016 · Cited by 708
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640
Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., & Barrett-Connor, E. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00005 · Cited by 633
for the Women’s Health Initiative Investigators, Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1448-x · Cited by 599
Grodstein, F., Manson, J. E., & Stampfer, M. J. (2006) · Journal of Women's Health · doi:10.1089/jwh.2006.15.35 · Cited by 479
Cited by
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Hormone-replacement therapy: current thinking
Lobo, R. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 484
Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1146 · Cited by 341
“Pereira (117) RCT 22 566 4 1 wk t-E2 50 mg Euglycemic, hyperinsulinemic clamp GDR ↑”
BackgroundHodis, H. N., & Mack, W. J. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000591 · Cited by 187
Sex Differences in Adipose Tissue Function
Gavin, K. M., & Bessesen, D. H. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.02.008 · Cited by 185
Estrogens in adipose tissue physiology and obesity-related dysfunction
Kuryłowicz, A. (2023) · Biomedicines · doi:10.3390/biomedicines11030690 · Cited by 178
Treating menopause — MHT and beyond
Davis, S. R., & Baber, R. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00685-4 · Cited by 172
Management of menopause: a view towards prevention
Lobo, R. A., & Gompel, A. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00269-2 · Cited by 172
Estrogen as a key regulator of energy homeostasis and metabolic health
Mahboobifard, F., Pourgholami, M. H., Jorjani, M., Dargahi, L., Amiri, M., Sadeghi, S., & Tehrani, F. R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113808 · Cited by 154
The role of sex steroids in white adipose tissue adipocyte function
Newell-Fugate, A. E. (2017) · Reproduction · doi:10.1530/rep-16-0417 · Cited by 114
Sex Hormones and Cardiometabolic Health: Role of Estrogen and Estrogen Receptors
Clegg, D., Hevener, A. L., Moreau, K. L., Morselli, E., Criollo, A., Van Pelt, R. E., & Vieira-Potter, V. J. (2017) · Endocrinology · doi:10.1210/en.2016-1677 · Cited by 123
Hormones and Aging: An Endocrine Society Scientific Statement
Cappola, A. R., Auchus, R. J., Fuleihan, G. E., Handelsman, D. J., Kalyani, R. R., McClung, M. R., Stuenkel, C. A., Thorner, M. O., & Verbalis, J. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad225 · Cited by 122
Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety
He, R., Finan, B., Mayer, J. P., & DiMarchi, R. D. (2019) · Molecules · doi:10.3390/molecules24101855 · Cited by 118
Sex and gender differences in therapy of type 2 diabetes
Kautzky‐Willer, A., & Harreiter, J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.012 · Cited by 117
Ketogenic diet as a potential intervention for lipedema
Keith, L., Seo, C. A., Rowsemitt, C. N., Pfeffer, M., Wahi, M. M., Staggs, M., Dudek, J. E., Gower, B. A., & Carmody, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110435 · Cited by 111
G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis
Sharma, G., & Prossnitz, E. R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_20 · Cited by 88
Marchand, G. B., Carreau, A.-M., Weisnagel, S. J., Bergeron, J., Labrie, F., Lemieux, S., & Tchernof, A. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00293.2017 · Cited by 73
Karvonen-Gutierrez, C. A., Park, S. K., & Kim, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0714-x · Cited by 73
Ahmed, F., Kamble, P. G., Hetty, S., Fanni, G., Vranic, M., Sarsenbayeva, A., Kristófi, R., Almby, K. E., Svensson, M. K. E., Pereira, M. J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac042 · Cited by 64
Menopause, hormone therapy and diabetes
Stuenkel, C. A. (2017) · Climacteric · doi:10.1080/13697137.2016.1267723 · Cited by 63
Gliemann, L., & Hellsten, Y. (2019) · The Journal of Physiology · doi:10.1113/jp277056 · Cited by 54
Time since menopause and skeletal muscle estrogen receptors, PGC-1α, and AMPK
Park, Y.-M., Pereira, R. I., Erickson, C. B., Swibas, T. A., Kang, C., & Van Pelt, R. E. (2017) · Menopause · doi:10.1097/gme.0000000000000829 · Cited by 44
Self-citationPark, Y.-M., Pereira, R. I., Erickson, C. B., Swibas, T., Cox‐York, K. A., & Pelt, R. E. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176446 · Cited by 45
Self-citationD’Costa, Z. U., Spertus, E., Hingorany, S., Patil, R., Horwich, T. B., Press, M. C., Shah, J. B., Watson, K. E., & Jafari, L. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01343-6 · Cited by 45
Candeias, E., Duarte, A. I., Sebastião, I., Fernandes, M. A. S., Plácido, A. I., Carvalho, C., Correia, S. C., Santos, R. X., Seiça, R. M. F., Santos, M. S., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0155-1 · Cited by 41
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong
Langer, R. D., Simon, J. A., Pines, A., Løbo, R. A., Hodis, H. N., Pickar, J. H., Archer, D. F., Sarrel, P. M., & Utian, W. H. (2017) · Climacteric · doi:10.1080/13697137.2017.1362156 · Cited by 40
Park, Y.-M., Keller, A. C., Runchey, S. S., Miller, B. F., Kohrt, W. M., Pelt, R. E. V., Kang, C., Jankowski, C. M., & Moreau, K. L. (2019) · Steroids · doi:10.1016/j.steroids.2019.03.008 · Cited by 37
Lee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
Menopause, Estrogens, and Glucose Homeostasis in Women
Mauvais‐Jarvis, F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_11 · Cited by 31
A theory of eu-estrogenemia: a unifying concept
Turner, R. J., & Kerber, I. J. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000895 · Cited by 23
Chronic estradiol exposure – harmful effects on behavior, cardiovascular and reproductive functions
MohanKumar, S. M. J., Balasubramanian, P., Subramanian, M., & MohanKumar, P. S. (2018) · Reproduction · doi:10.1530/rep-18-0116 · Cited by 23
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong
Langer, R. D., Simon, J. A., Pines, A., Løbo, R. A., Hodis, H. N., Pickar, J. H., Archer, D. F., Sarrel, P. M., & Utian, W. H. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000983 · Cited by 18
Influence of menopausal hormone therapy on body composition and metabolic parameters
Costa, G. B. C., Carneiro, G., Umeda, L., Pardini, D., & Zanella, M. T. (2020) · BioResearch Open Access · doi:10.1089/biores.2019.0050 · Cited by 17
“menopause) compared with a decrease when administered to late postmenopausal women (>10 years past menopause).(19) In our study, despite this significance, we observed that the HT group had lower fasting insulin levels and HOMA-IR, after 6 months.”
MethodPersky, V., Abasilim, C., Tsintsifas, K., Day, T., Sargis, R. M., Daviglus, M. L., Cai, J., Freels, S. A., Unterman, T. G., Chávez, N., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad018 · Cited by 19
Kang, S. Y., Park, Y., Kwon, D. J., Chung, Y., Namkung, J., Han, K., & Ko, S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0135 · Cited by 15
Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment
Hugenschmidt, C. E., Duran, T., & Espeland, M. A. (2021) · Climacteric · doi:10.1080/13697137.2021.1877652 · Cited by 15
A conversation about hormone therapy: is there an appropriate dose, route, and duration of use?
(2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000986 · Cited by 11
Ebong, I., Watson, K. E., Hairston, K. G., Carnethon, M. R., Ouyang, P., Szklo, M., & Bertoni, A. G. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.06.020 · Cited by 10
Teixeira, C. J., Ribeiro, L. M., Veras, K. M. D. A., Araujo, L. C. D. C., Curi, R., & Carvalho, C. R. D. O. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.052 · Cited by 10
Hung, M., Chang, N., Hu, P., Chen, T., Mao, C., Yeh, C., & Hung, M. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.57987 · Cited by 9
Yureneva, S. V., & Dubrovina, A. V. (2018) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20181805149 · Cited by 8
Khan, M. M., Khan, Z. A., & Khan, M. A. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v14.i6.767 · Cited by 7
Hairi, H. A., Ibrahim, N. ‘., Sadikan, M. Z., Jayusman, P. A., & Shuid, A. N. (2024) · Bioimpacts · doi:10.34172/bi.30378 · Cited by 7
Ramírez‐Hernández, D., López‐Sánchez, P., Lezama‐Martínez, D., Kuyoc-Arroyo, N. M., Rodríguez-Rodríguez, J. E., Fonseca-Coronado, S., Valencia‐Hernández, I., & Flores‐Monroy, J. (2023) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1155/2023/6683989 · Cited by 7
Ball, B. K., Proctor, E. A., & Brubaker, D. K. (2024) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789819807024_0031 · Cited by 7
García‐Arévalo, M., Lorza‐Gil, E., Leite, N. C., Brunetto, S. Q., Boschero, A. C., & Carneiro, E. M. (2019) · Journal of Endocrinology and Metabolism · doi:10.14740/jem612 · Cited by 6
Women and psychosis: a guide to evidence-based, hormone-informed care
Brand, B. A., Behrman, S., Marwick, K. F. M., Reilly, T. J., Sommer, I. E., Talaulikar, V. S., & McCutcheon, R. A. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(26)00016-7 · Cited by 5
Role of de novo lipogenesis in insulin resistance in first-episode psychosis and therapeutic options
Khan, M. M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104919 · Cited by 5
Posicionamiento AEEM-SEGO sobre la terapia hormonal de la menopausia
Sánchez‐Borrego, R., Coto, P. L., de Guevara, N. M. L., Delgado, R. C., Barriendos, J. F., Baquedano, L., Jurado, A. R., Manubens, M., García-Ramos, B. O., López, D. M. L., et al. (2019) · Progresos de Obstetricia y Ginecología · doi:10.20960/j.pog.00094 · Cited by 3
Hormonal regulation in diabetes: Special emphasis on sex hormones and metabolic traits
Ravi, H., Das, S., Rajeswari, V. D., Venkatraman, G., Choudhury, A. A., Chakraborty, S., & Ramanathan, G. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.12.015 · Cited by 3
Anderson, E. (2017) · The Atrium (University of Guelph) · Cited by 3
Metabolic effects of late-onset estradiol replacement in high-fat-fed ovariectomized mice
Cruz, A. G. D., Santos, J. D. M. D., Alves, E. D. S., Santos, A. R. M. D., Trinca, B. F., Camargo, F. N. D., Bovolin, G. F., & Camporez, J. P. (2025) · Current Research in Physiology · doi:10.1016/j.crphys.2025.100144 · Cited by 2
Anderson, E., Cervone, D. T., & Dyck, D. J. (2018) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v8i2.405 · Cited by 2
Vaskiv, О. V., Григоренко, А. П., Horbatiuk, О. H., Shatkovska, A. S., & Binkovska, A. (2019) · Biomedical and Biosocial Anthropology · doi:10.31393/bba35-2019-07 · Cited by 2
Peptide‐small Molecule Drug Conjugates for Cancer, Metabolic Diseases, and Beyond
He, R., Singh, S., & Mezo, A. R. (2025) · Peptide Science · doi:10.1002/9781119824701.ch12 · Cited by 1
Liang, C., Dobson, A. J., Doust, J. A., Ribeiro, L. W., & Mishra, G. D. (2026) · Diabetologia · doi:10.1007/s00125-026-06856-6 · Cited by 1
Macrophage stimulating protein (MSP) in the metabolic syndrome
Li, ‡. (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170908jl · Cited by 1
Impacto da Menopausa no controlo da Diabetes Mellitus tipo 2
Amorim, M. A. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Pharmacotherapies for Menopause Management: Hormonal Options
Pinkerton, J. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-42451-4_4
Tramunt, B., & Gourdy, P. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-74372-6.00023-0
Menopausal Hormone Therapy and Prevention of Cardiovascular Disease
Fidecicchi, T., Caretto, M., Giannini, A., Luisi, S. V., & Simoncini, T. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_5
Menopausal Hormone Therapy and Diabetes
Lovre, D., & Mauvais‐Jarvis, F. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_6
Candeias, E. M. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Vaihdevuosien aikaisen hormonihoidon yhteys metaboliseen terveyteen
Virkki, A. I. E. (2024) · Jyväskylä University Digital Archive (University of Jyväskylä)
Ahmed, F. (2024) · Uppsala University Publications (Uppsala University)
Impact of Menopause and Menopausal Hormone Therapy on Liver–Kidney–Metabolic Health
Jamalinia, M., Lonardo, A., & Weiskirchen, R. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03758-2 · Cited by 1
Acute Effects of Aromatase Inhibitor Therapy for Breast Cancer on Glycemic Control
Lee, O. R. (2026) · TSpace (University of Toronto)
Menopause and the opportunity for early cardio-renal-metabolic prevention
Anggiat, E., Trishna, T., Wijaya, J. F., Nasution, S. A., Amansyah, A., Silaen, M., Sina, I., Wilonna, A., Nasution, C. R., Putra, I. A., et al. (2026) · Buletin Kedokteran & Kesehatan Prima · doi:10.34012/bkkp.v5i2.8661
Parten, A. L., & Rowe, G. C. (2026) · Physiological Reports · doi:10.14814/phy2.71155
Khoudary, S. R. E., Deckey, I., Fidecicchi, T., & Simoncini, T. (2026) · Climacteric · doi:10.1080/13697137.2026.2745378
Navarro, R., Exposito, T., Quereda, C., Serrano‐Maciá, M., Nadal, Á., & Martínez‐Pinna, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.10.763916
Metadata
- Authors
- Pereira, R. I., Casey, B. A., Swibas, T. A., Erickson, C. B., Wolfe, P., & Van Pelt, R. E.
- Affiliations
- Division of Geriatric Medicine; Department of Medicine (R.I.P., B.A.C.), Division of Endocrinology, Metabolism and Diabetes
- Department of Medicine (T.A.S., C.B.E., R.E.V.P.), Aurora, Colorado 80045
- Colorado School of Public Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-12-01
- Volume
- 100
- Issue
- 12
- Pages
- 4456-4462
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4667161
- OpenAlex
- W1680854225
- Cited by
- 59
- References
- 42
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 3 · 2019: 7 · 2018: 4 · 2017: 16 · 2016: 5
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research
- National Institutes of Health (UL1TR000154, UL1TR001082)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088105, T32DK007446, P30DK048520)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD073063)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- estradiol, hormone therapy, menopause, insulin sensitivity, glucose disposal rate, type 2 diabetes risk, postmenopausal women, timing of hormone therapy, transdermal estradiol, fat-free mass, hyperinsulinemic-euglycemic clamp, cardiometabolic health, age at menopause, body composition, skeletal muscle
- MeSH terms
- Age Factors, Aged, Body Composition, Diabetes Mellitus, Type 2, Estradiol, Female, Glucose, Glucose Tolerance Test, Humans, Insulin Resistance, Middle Aged, Motor Activity, Glucose Clamp Technique, Estrogen Replacement Therapy, Body Mass Index, Treatment Outcome, Postmenopause, Cross-Over Studies, Risk Reduction Behavior, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.